Stock has given staggering 68 per cent returns in less than a month of its listing. Sales has doubled in past three years.

This BSE small-cap top gainer climbed over 13 per cent today; do you own it?

This pharma company stock went 8 per cent high, do you own it?                                                                                                                                                                                                       With its shares up 8 per cent, the Indian multinational pharmaceutical company posted a net profit of Rs 130 crore in the second quarter, while its turnover increased to Rs 4,145 crore.

The stock also witnessed a triangular consolidation pattern of 27 trading sessions and has been trading above its 20-DMA. Moreover, the 20-DMA is on a rising trajectory. The daily 14-period RSI is seen rebounding after forming a base at the nine-period average thereby, supporting the positive bias.

Net profit margin is one of thekey tools for determining thefinancial health of a company.The metric demonstrates acompany’s ability to convertsales into profits and alsofurnishes an insight into how wella company is run. Armaan Madhani explains how investorsmust properly analyse thevarious facets of profitability